JP2017529346A5 - - Google Patents

Download PDF

Info

Publication number
JP2017529346A5
JP2017529346A5 JP2017514615A JP2017514615A JP2017529346A5 JP 2017529346 A5 JP2017529346 A5 JP 2017529346A5 JP 2017514615 A JP2017514615 A JP 2017514615A JP 2017514615 A JP2017514615 A JP 2017514615A JP 2017529346 A5 JP2017529346 A5 JP 2017529346A5
Authority
JP
Japan
Prior art keywords
pyrimidin
pharmaceutically acceptable
acceptable salt
pyrido
phenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017514615A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017529346A (ja
JP6552608B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/050432 external-priority patent/WO2016044429A1/en
Publication of JP2017529346A publication Critical patent/JP2017529346A/ja
Publication of JP2017529346A5 publication Critical patent/JP2017529346A5/ja
Application granted granted Critical
Publication of JP6552608B2 publication Critical patent/JP6552608B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017514615A 2014-09-17 2015-09-16 ヒストンデメチラーゼ阻害剤 Expired - Fee Related JP6552608B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462051691P 2014-09-17 2014-09-17
US62/051,691 2014-09-17
PCT/US2015/050432 WO2016044429A1 (en) 2014-09-17 2015-09-16 Histone demethylase inhibitors

Publications (3)

Publication Number Publication Date
JP2017529346A JP2017529346A (ja) 2017-10-05
JP2017529346A5 true JP2017529346A5 (enExample) 2018-10-25
JP6552608B2 JP6552608B2 (ja) 2019-07-31

Family

ID=55525128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017514615A Expired - Fee Related JP6552608B2 (ja) 2014-09-17 2015-09-16 ヒストンデメチラーゼ阻害剤

Country Status (17)

Country Link
US (7) US9643965B2 (enExample)
EP (2) EP3193601B1 (enExample)
JP (1) JP6552608B2 (enExample)
KR (1) KR20170048591A (enExample)
CN (1) CN107205391A (enExample)
AU (1) AU2015317806A1 (enExample)
BR (1) BR112017005511A2 (enExample)
CA (1) CA2961610A1 (enExample)
CL (1) CL2017000659A1 (enExample)
CO (1) CO2017003538A2 (enExample)
EA (1) EA201790603A1 (enExample)
EC (1) ECSP17023551A (enExample)
ES (1) ES2910226T3 (enExample)
IL (1) IL251179A0 (enExample)
MX (1) MX2017003466A (enExample)
SG (1) SG11201702147TA (enExample)
WO (1) WO2016044429A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2970211T (pt) 2013-03-15 2017-10-31 Quanticel Pharmaceuticals Inc Inibidores de histona demetilase
MX2017003466A (es) 2014-09-17 2017-07-13 Celgene Quanticel Res Inc Inhibidores de histona desmetilasa.
EP3430008B1 (en) * 2016-03-15 2022-05-18 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
US10150754B2 (en) 2016-04-19 2018-12-11 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
MA45887B1 (fr) 2016-11-28 2021-04-30 Teijin Pharma Ltd Cristal de dérivé de pyrido [3, 4-d] pyrimidine ou son solvate
US11040973B2 (en) 2017-03-29 2021-06-22 Purdue Research Foundation Inhibitors of kinase networks and uses thereof
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
EP4074317A1 (en) 2021-04-14 2022-10-19 Bayer AG Phosphorus derivatives as novel sos1 inhibitors
CN115368252B (zh) * 2022-09-19 2024-01-12 西北农林科技大学 一种4-胺基酚类衍生物及应用
CN116253712B (zh) * 2023-03-27 2025-05-02 昆山市第一人民医院 5,6,7-三甲氧基-2,3-二氢喹啉类化合物、药物组合物及用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4383870B2 (ja) * 2001-10-17 2009-12-16 協和発酵キリン株式会社 線維芽細胞増殖因子受容体自己リン酸化を阻害するキノリン誘導体およびキナゾリン誘導体並びにそれらを含有する医薬組成物
EP1485380B1 (en) 2002-03-15 2010-05-19 Vertex Pharmaceuticals Incorporated Azolylaminoazines as inhibitors of protein kinases
BRPI0410720A (pt) * 2003-05-27 2006-06-20 Pfizer Prod Inc quinazolinas e pirido[3,4-d]pirimidinas como inibidores do receptor de tirosina cinase
WO2006036395A2 (en) * 2004-08-23 2006-04-06 Merck & Co., Inc. Inhibitors of akt activity
FR2876103B1 (fr) 2004-10-01 2008-02-22 Aventis Pharma Sa Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
KR20090077914A (ko) 2006-09-11 2009-07-16 쿠리스 인코퍼레이션 항증식제로서의 다작용성 소분자
TW200922590A (en) 2007-09-10 2009-06-01 Curis Inc VEGFR inhibitors containing a zinc binding moiety
JP5552608B2 (ja) 2012-04-27 2014-07-16 株式会社ソフイア 遊技機
HUE033380T2 (en) 2012-10-02 2017-11-28 Gilead Sciences Inc Inhibitors of histone demethylases
SMT201800070T1 (it) 2012-12-19 2018-03-08 Celgene Quanticel Res Inc Inibiorti di istone demetilasi
SG11201504946VA (en) 2012-12-21 2015-07-30 Quanticel Pharmaceuticals Inc Histone demethylase inhibitors
US9738637B2 (en) 2013-03-12 2017-08-22 Celgene Quantical Research, Inc. Histone demethylase inhibitors
PT2970211T (pt) 2013-03-15 2017-10-31 Quanticel Pharmaceuticals Inc Inibidores de histona demetilase
KR20150130451A (ko) 2013-03-15 2015-11-23 제넨테크, 인크. 암 치료 방법 및 항암제 내성 예방을 위한 방법
AR100997A1 (es) 2014-06-25 2016-11-16 Quanticel Pharmaceuticals Inc Derivados de piridina como inhibidores de histona demetilasa
MX2017003466A (es) 2014-09-17 2017-07-13 Celgene Quanticel Res Inc Inhibidores de histona desmetilasa.
US10030017B2 (en) 2014-09-17 2018-07-24 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
EP3430008B1 (en) 2016-03-15 2022-05-18 Celgene Quanticel Research, Inc. Histone demethylase inhibitors

Similar Documents

Publication Publication Date Title
JP2017529346A5 (enExample)
JP2023027269A5 (enExample)
JP2017530962A5 (enExample)
HRP20151001T4 (hr) Sredstva kao induktori apoptoze za liječenje raka te imunih i autoimunih bolesti
RU2004117887A (ru) Ариланилиновые агонисты бета2 адренергических рецепторов
HRP20141094T1 (hr) 1,2,5-oksadiazoli kao inhibitori indolamin 2,3-dioksigenaze
JP2010517946A5 (enExample)
HRP20200341T1 (hr) Bromodomenski (bet) inhibitori
JP2007523867A5 (enExample)
JP2008110984A5 (enExample)
JP2018507899A5 (enExample)
JP2013542937A5 (enExample)
JP2004525951A5 (enExample)
JP2013505969A5 (enExample)
JP2005509024A5 (enExample)
JP2013532727A5 (enExample)
JP2016501250A5 (enExample)
JP2010501587A5 (enExample)
JP2012255002A5 (enExample)
JP2013534245A5 (enExample)
JP2007501831A5 (enExample)
JP2018529770A5 (enExample)
JP2007519695A5 (enExample)
JP2013505949A5 (enExample)
JP2005521650A5 (enExample)